http://www.fpnotebook.com/
Pentamidine
Aka: Pentamidine, Pentam, NebuPent- Indications: Human Immunodeficiency Virus (HIV)
- Dosing
- Pneumocystis Pneumonia Treatment
- Parenteral: 4 mg/kg/day IV or IM
- Pneumocystis prophylaxis
- Nebulized (NebuPent): 300 mg nebulized every 4 weeks
- Pneumocystis Pneumonia Treatment
- Adverse Reactions
- Neutropenia (15%)
- Thrombocytopenia
- Hypocalcemia
- Nephrotoxicity and Renal insufficiency
- Hepatitis
- Pancreatitis
- Dysglycemia (20% treated for 3 weeks)
- Pentamidine causes pancreatic islet cell toxicity
- Hypoglycemia
- Hyperglycemia
- Gastrointestinal Upset (Nausea or Vomiting)
- Rash
Pentamidine (C0030863) |
|
|---|---|
| Definition (NCI) | The active ingredient in a drug used to treat infections caused by certain microorganisms. It is also being studied in the treatment of melanoma. It prevents DNA from being copied and may kill cancer cells. It is a type of antifungal agent, a type of antiprotozoal agent, and a type of PRL phosphatase inhibitor. |
| Definition (MSH) | Antiprotozoal agent effective in trypanosomiasis, leishmaniasis, and some fungal infections; used in treatment of PNEUMOCYSTIS pneumonia in HIV-infected patients. It may cause diabetes mellitus, central nervous system damage, and other toxic effects. |
| Definition (NCI) | A synthetic derivative of amidine with antiprotozoal and antifungal activities. Although the precise mode of action of pentamidine is unclear, it appears to interact directly with the pathogen genome by binding to AT-rich regions of duplex DNA and the minor groove of DNA, thereby interfering with DNA replication. (NCI04) |
| Definition (CSP) | 4,4-diamidino-alpha,omega-dephenoxypentane (HCl); effective against Pneumocystis carinii, a cause of AIDS related pneumonia. |
| Definition (PDQ) | A synthetic derivative of amidine with antiprotozoal and antifungal activities. Although the precise mode of action of pentamidine is unclear, it appears to interact directly with the pathogen genome by binding to AT-rich regions of duplex DNA and the minor groove of DNA, thereby interfering with DNA replication. Check for "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=40324&idtype=1" active clinical trials or "http://www.cancer.gov/Search/ClinicalTrialsLink.aspx?id=40324&idtype=1&closed=1" closed clinical trials using this agent. ("http://nciterms.nci.nih.gov:80/NCIBrowser/ConceptReport.jsp?dictionary=NCI_Thesaurus&code=C731" NCI Thesaurus) |
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D010419 |
| SnomedCT | 31692006, 372699006 |
| English | Pentamidin, pentamidine, Benzenecarboximidamide, 4,4'-(1,5-pentanediylbis(oxy))bis-, Aerosolized Pentamadine, pentamidine (medication), Pentamidine [Chemical/Ingredient], pentamidin, Pentamidine (product), Pentamidine (substance), Pentamidine, PENTAMIDINE |
| Swedish | Pentamidin |
| Czech | pentamidin |
| Finnish | Pentamidiini |
| Russian | PENTAMIDIN, PENTAMIDINA IZOTIONAT, ПЕНТАМИДИН, ПЕНТАМИДИНА ИЗОТИОНАТ |
| Japanese | イセチオン酸ペンタミジン, ペンタミジン |
| Polish | Pentamidyna |
| Spanish | pentamidina (producto), pentamidina (sustancia), pentamidina, Pentamidina |
| French | Pentamidine |
| German | Pentamidin |
| Italian | Pentamidina |
| Portuguese | Isetionato de Pentamidina, Isotionato de Pentamidina, Pentamidina |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
NebuPent (C0722005) |
|
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D010419 |
| English | pentamidine aerosol, pentamidine aerosol (medication), Nebupent, American Pharmaceutical Partners Brand 1 of Pentamidine Isethionate, NebuPent |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |
Pentam (C1518952) |
|
|---|---|
| Concepts | Organic Chemical (T109) , Pharmacologic Substance (T121) |
| MSH | D010419 |
| English | Pentam, American Pharmaceutical Partners Brand 2 of Pentamidine Isethionate |
| Sources |
Derived from the NIH UMLS (Unified Medical Language System) |